Philips & Baxter Medical
OR table
Philips & Baxter Medical
OR table
The Philips Azurion imaging system, in combination with the Baxter Medical Trusystem 7500 Hybrid Plus, combines leading-edge interventional X-ray with a leading-edge OR table. A setup that will provide you with a truly multifunctional room where you can perform interventional, hybrid, and traditional surgical procedures.
Features
Excellent flexibility and efficiency
When a leading edge interventional X-ray system works side-by-side with a leading edge OR table,
your medical teams benefit from excellent flexibility. The Baxter Medical OR table provides
extreme adjustment angles and positions to support a full range of surgical procedures.
Fast and confident positioning
The Philips Azurion with FlexArm and Baxter Medical OR table are interfaced to work smoothly and flexibly with each other. The interface between the Azurion stand and the Baxter OR table* facilitates the stop of gantry and table movements after a Bodyguard signal so you can move the Azurion at high speeds with confidence.
Smooth and easy control
Intuitively pan and free-float the Baxter Medical tabletop Carbon FloatLine with the Sensor Control FloatLine handle. The Azurion C-arm stand and Baxter Medical OR table are controlled via their individual control modules.
Related products
- This ceiling-mounted system provides unlimited imaging flexibility for diverse procedures and exceptional positioning freedom for medical teams. Its compact set-up provides a highly cost-effective environment, ready for the procedures of the future. Seamlessly control all relevant applications from a single touch screen at table side, to help make fast, informed decisions in the sterile field. By working around you, Philips Azurion with FlexArm helps you advance your suite performance and deliver superior care.
- ClarityIQ technology provides high quality imaging for a variety of clinical procedures. It delivers excellent visibility at low X-ray dose levels for patients of all sizes. Multiple clinical studies on more than 19000 patients have been published on ClarityIQ technology to date revealing one truth: significantly lower dose across clinical areas, patients and operators.
